Sep 6, 2021
Neil Barker Joins MediSieve as a Quality Manager
Neil brings to MediSieve a 40-year track record in quality and regulatory affairs.
"Neil's extensive experience in regulatory strategy and operations across multiple applications will be a tremendous addition to the MediSieve team," said William Twigger, Head of Engineering and Quality of MediSieve. "We are thrilled to have Neil join us at such an important time for our company as we are about to begin our first in-man trials."
Neil has demonstrated exceptional leadership in medtech regulatory affairs throughout his career. Prior to joining MediSieve, he oversaw quality and regulatory activities at several publicly traded medical device companies, including Advanced Oncotherapy plc and e2v technologies, as well as dialysis equipment manufacturers like Quanta Dialysis Technologies. Neil has been a member of the Society of Environmental Engineers Council for over ten years, serving as Treasurer, Vice Chairman, and Chairman.
About Magnetic Blood Filtration
MediSieve's Magnetic Blood Filtration Platform is intended to enable the rapid and specific depletion of specific agents from the bloodstream of patients. The extracorporeal therapy uses therapeutic Magnetic Beads that are designed to bind specifically to the clinical target. The Beads are introduced into the extracorporeal circuit during the therapy, mixing with the patient’s blood and binding to the clinical targets. The Delivery Platform captures all the Magnetic Beads and bound targets, preventing their return to the patient.
About MediSieve
MediSieve is a London-based BioTech start-up that has developed Magnetic Blood Filtration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used (1) as a direct treatment, (2) to increase the safety and efficacy of other therapies, or (3) to enable personalised medicine. The company is a spin-off from University College London and is developing its products at the White City Innovation District in West London. MediSieve is actively seeking investment and partnerships.
MEDIA CONTACT:
Alina Kagermazova
INVESTOR AND PARTNERSHIP CONTACT:
George Frodsham
